Search This Blog

Saturday, January 9, 2021

Buy Solid Biosciences (SLDB) on Weakness - Chardan Capital

 Chardan Capital Markets analyst Gbola Amusa reiterated a Buy rating and $12.50 price target on Solid Biosciences (NASDAQ: SLDB)

https://www.streetinsider.com/Analyst+Comments/Buy+Solid+Biosciences+%28SLDB%29+on+Weakness+-+Chardan+Capital/17801748.html

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)